Quantcast

Fashion Guru Nina Garcia Announces Winner of National Design Competition

September 9, 2008

WAYNE, N.J., Sept. 9 /PRNewswire/ — Nina Garcia, judge of the Emmy-nominated series Project Runway, and the Step Up Women’s Network are proud to announce the winner of the “YAZ(R): Step Up and Go Beyond” contest — aspiring handbag designer Elayne Mayes of Green Village, New Jersey. Elayne’s winning design will allow her to jumpstart her fashion design career with a $10,000 prize.

Designed to empower women to go beyond what they thought was possible and achieve their career goals, the “YAZ: Step Up and Go Beyond” contest gave designer hopefuls from all across the country the opportunity to enter contemporary and edgy new carrying case concepts for the oral contraceptive YAZ(R) (drospirenone & ethinyl estradiol). As a result, more than two hundred people entered, from aspiring designers and graphic artists to office fashionistas with a flair for what’s chic — all for the chance to win and to help advance their dreams of becoming a designer.

“I was really impressed with the creativity and professionalism of the entries, but what really stood out to me about the winner’s new design for the YAZ carrying case was that it’s not only edgy and fashion-forward, but also functional and discreet,” Garcia explained. “And with its fun print and studded closure, I can definitely see a woman slipping this carrying case into her purse.”

Garcia, in partnership with Step Up Women’s Network, a nonprofit charitable organization dedicated to mentoring and empowering young women for advancement, and Bayer HealthCare Pharmaceuticals launched the contest in April 2008. The contest winner was awarded a $10,000 grand prize.

“I’m so excited that my design won! I am planning to use my prize money to enroll in computer design classes,” said winner Elayne Mayes. “But, for me, the real win was having my design concept hand-selected by one of the biggest forces in the fashion industry today — Nina Garcia.”

The winner’s design of the new YAZ carrying case along with the other top nine entries can be viewed online at http://www.pillpackmakeover.com/. The winning design will also be available in limited edition in 2009 online at YAZ-US.com. A portion of the proceeds will be donated to the Step Up Women’s Network.

About the “YAZ: Step Up and Go Beyond” Contest

Launched in April 2008, the “YAZ: Step Up and Go Beyond” contest was a design competition open to people ages 18 years or older. Registration was available online at http://www.pillpackmakeover.com/. Here, designers were able to submit an electronic file of their design along with a 100-word description. Entries were judged on the following criteria:

   --  Most embodies the theme of female empowerment (25%)   --  Most creative and original (25%)   --  Most discreet (25%)   --  Most fashion forward and stylish (25%)   

Judges of the contest included Nina Garcia of Project Runway, Executive Director of Step Up Women’s Network Danielle Carrig and Lauren Streicher, MD, Assistant Clinical Professor of Obstetrics and Gynecology at Northwestern University, Chicago. The contest was sponsored by Bayer HealthCare, in partnership with Nina Garcia and Step Up Women’s Network.

Putting a Spotlight on Health

YAZ is the first and only oral contraceptive approved to treat the emotional and physical premenstrual symptoms severe enough to impact a woman’s life. These symptoms, called premenstrual dysphoric disorder (PMDD), can include irritability, fatigue, moodiness, feeling anxious and bloating. These symptoms can also significantly impact a woman’s quality of life interfering with school, work and personal relationships with others. YAZ is the only oral contraceptive (OC) that has been shown to be effective in clinical studies to reduce monthly menstrual symptoms and improve quality of life in women with PMDD.

In addition, YAZ is proven effective in treating moderate acne in appropriate women seeking contraception. In recent studies, nine out of 10 women taking YAZ saw improvement in their moderate acne. YAZ is the first and only oral contraceptive on the market clinically proven to treat both PMDD and moderate acne, providing women with health benefits beyond birth control

About Step Up Women’s Network

Step Up Women’s Network is a national non-profit membership organization dedicated to strengthening community resources for young women. Through empowerment programs, women’s health education and advocacy, professional mentorship and social networking opportunities, the organization aims to educate and activate their members to ensure that women have the tools they need to create a better future.

Step Up is on the cutting edge of women’s social philanthropy. The programs are designed to engage women in a way that inspires a life-long commitment to responsible, philanthropic involvement encompassing hands-on volunteer work and leadership opportunities. For more information, please log on to http://www.suwn.org/.

About YAZ

YAZ(R) (drospirenone and ethinyl estradiol) is indicated for the prevention of pregnancy in women who elect to use an oral contraceptive. YAZ is also indicated for the treatment of symptoms of premenstrual dysphoric disorder (PMDD) in women who choose to use an oral contraceptive as their method of contraception. The effectiveness of YAZ for PMDD when used for more than three menstrual cycles has not been evaluated. YAZ has not been evaluated for the treatment of premenstrual syndrome (PMS).

YAZ is indicated for the treatment of moderate acne vulgaris in women at least 14 years of age, who have no known contraindications to oral contraceptive therapy and have achieved menarche. YAZ should be used for the treatment of acne only if the patient desires an oral contraceptive for birth control.

Women who would like to learn more about YAZ should call the toll-free number 1-888-84-BAYER or visit http://www.yaz-us.com/.

   Important Safety Information About YAZ(R)    What is YAZ Prescribed For?  

YAZ is indicated for the prevention of pregnancy in women who elect to use an oral contraceptive. YAZ is also indicated for the treatment of symptoms of premenstrual dysphoric disorder (PMDD) in women who choose to use an oral contraceptive as their method of contraception. The effectiveness of YAZ for PMDD when used for more than 3 menstrual cycles has not been evaluated. YAZ has not been evaluated for the treatment of premenstrual syndrome (PMS).

YAZ is indicated for the treatment of moderate acne vulgaris in women at least 14 years of age, who have no known contraindications to oral contraceptive therapy and have achieved menarche. YAZ should be used for the treatment of acne only if the patient desires an oral contraceptive for birth control.

Who Shouldn’t Take YAZ(R)

YAZ contains a different kind of hormone, drsp(R) (drospirenone), which may increase potassium. Therefore, you should not take YAZ if you have kidney, liver, or adrenal disease because this could cause serious heart and health problems. Tell your doctor if you are on long-term treatment for a chronic condition such as cardiovascular disease or chronic inflammatory disease. Women who take certain drugs (See Below) should have their potassium levels checked in the first month of taking YAZ.

What are some examples of cardiovascular or chronic inflammatory drugs that may increase potassium? NSAIDs-ibuprofen (Motrin(R), Advil(R)), naproxen (Naprosyn(R), Aleve(R), and others), when taken long-term and daily for arthritis or other diseases or conditions–Potassium-sparing diuretics (spironolactone and others), Potassium supplementation, ACE inhibitors (Capoten(R), Vasotec(R), Zestril(R), and others), angiotensin-II receptor antagonists (Cozaar(R), Diovan(R), Avapro(R), and others), aldosterone antagonists, and heparin.

What Are Possible Side Effects Involved With Taking YAZ?

What are the risks involved with taking any oral contraceptive (OC)? OCs can be associated with increased risks of several serious side effects. OCs do not protect against HIV infection or other STDs. Women, especially those 35 and over, are strongly advised not to smoke because it increases the risk of serious cardiovascular side effects including blood clots, stroke, and heart attack.

The most frequent (>1%) treatment-emergent adverse events, listed in descending order, reported with the use of YAZ in the contraception clinical trials, which may or may not be drug-related, included: upper respiratory infection, headache, breast pain, vaginal moniliasis, leukorrhea, diarrhea, nausea, vomiting, vaginitis, abdominal pain, flu syndrome, dysmenorrhea, moniliasis, allergic reaction, urinary tract infection, accidental injury, cystitis, tooth disorder, sore throat, infection, fever, surgery, sinusitis, back pain, emotional lability, migraine, suspicious Papanicolaou smear, dyspepsia, rhinitis, acne, gastroenteritis, bronchitis, pharyngitis, skin disorder, intermenstrual bleeding, decreased libido, weight gain, pain, depression, increased cough, dizziness, menstrual disorder, pain in extremity, pelvic pain, and asthenia.

The most frequent (>1%) treatment-emergent adverse events, listed in descending order, reported with the use of YAZ in the PMDD clinical trials, which may or may not be drug-related, included: intermenstrual bleeding, headache, nausea, breast pain, upper respiratory infection, asthenia, abdominal pain, decreased libido, emotional lability, suspicious Papanicolaou smear, nervousness, menorrhagia, pain in extremity, depression, menstrual disorder, migraine, sinusitis, weight gain, vaginal moniliasis, vaginitis, hyperlipidemia, back pain, diarrhea, increased appetite, enlarged abdomen, accidental injury, acne, dysmenorrhea, and urinary tract infection.

The most frequent (>1%) treatment-emergent adverse events, listed in descending order, reported with the use of YAZ in the acne clinical trials, which may or may not be drug-related, included: upper respiratory infection, metrorrhagia, headache, suspicious Papanicolaou smear, nausea, sinusitis, vaginal moniliasis, flu syndrome, menorrhagia, depression, emotional lability, abdominal pain, gastroenteritis, urinary tract infection, tooth disorder, infection, vomiting, pharyngitis, breast pain, dysmenorrhea, menstrual disorder, accidental injury, asthenia, sore throat, weight gain, arthralgia, bronchitis, rhinitis, amenorrhea, and urine abnormality.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit http://www.fda.gov/medwatch, or call 1-800-FDA-1088.

Motrin is a registered trademark of Johnson & Johnson Company. Advil is a registered trademark of Wyeth Consumer Healthcare Inc. Naprosyn is a registered trademark of Hoffmann-La Roche Inc. Aleve is a registered trademark of Bayer Healthcare LLC. Capoten is a registered trademark of Par Pharmaceutical, Inc. Vasotec is a registered trademark of Merck & Company, Inc. Zestril is a registered trademark of AstraZeneca Pharmaceutical. Cozaar is a registered trademark of E.I. du Pont de Nemours and Company. Diovan is a registered trademark of Novartis Corporation. Avapro is a registered trademark of Sanofi-Aventis.

About Bayer HealthCare Pharmaceuticals Inc.

Bayer HealthCare Pharmaceuticals Inc. is the U.S.-based pharmaceuticals operation of Bayer HealthCare LLC, a division of Bayer AG. One of the world’s leading, innovative companies in the healthcare and medical products industry, Bayer HealthCare combines the global activities of the Animal Health, Consumer Care, Diabetes Care, and Pharmaceuticals divisions. In the United States, Bayer HealthCare Pharmaceuticals comprises the following business units: Women’s Healthcare, Diagnostic Imaging, Specialty Medicine, Hematology, and Oncology. The company’s aim is to discover and manufacture products that will improve human health worldwide by diagnosing, preventing and treating diseases.

Bayer HealthCare

CONTACT: Heather Levis, Bayer HealthCare Pharmaceuticals,+1-973-305-5313, heather.levis@bayer.com; or Amy Feldman of Ogilvy PublicRelations for Bayer HealthCare, +1-212-880-5380, amy.feldman@ogilvypr.com

Web Site: http://www.fda.gov/medwatchhttp://www.pillpackmakeover.com/http://www.suwn.org/http://www.yaz-us.com/




comments powered by Disqus